Kelly Shi
Stock Analyst at Jefferies
(1.95)
# 2,952
Out of 4,843 analysts
30
Total ratings
39.29%
Success rate
-5.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Initiates: Buy | $105 | $69.73 | +50.58% | 1 | May 13, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $18.22 | +141.56% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $7.52 | +99.47% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $26.95 | +92.95% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.10 | +241.46% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $13.51 | +40.64% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $162.73 | +20.44% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $1.93 | +988.08% | 1 | Aug 13, 2024 | |
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $37 | $10.54 | +251.04% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $0.72 | +730.11% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $48.52 | -5.19% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $65.06 | +24.50% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.31 | +64.28% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.87 | +1,825.13% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $39.01 | -58.98% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $29.64 | +34.95% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.18 | +378.47% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.66 | +200.75% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.72 | +3,658.88% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.90 | +274.10% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.82 | +3,184.67% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.94 | +1,601.03% | 1 | Mar 8, 2021 |
Insmed
May 13, 2025
Initiates: Buy
Price Target: $105
Current: $69.73
Upside: +50.58%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $18.22
Upside: +141.56%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $7.52
Upside: +99.47%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $26.95
Upside: +92.95%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.10
Upside: +241.46%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $13.51
Upside: +40.64%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $162.73
Upside: +20.44%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $1.93
Upside: +988.08%
Syndax Pharmaceuticals
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $10.54
Upside: +251.04%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $0.72
Upside: +730.11%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $48.52
Upside: -5.19%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $65.06
Upside: +24.50%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $21.31
Upside: +64.28%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.87
Upside: +1,825.13%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $39.01
Upside: -58.98%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $29.64
Upside: +34.95%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.18
Upside: +378.47%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.66
Upside: +200.75%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.72
Upside: +3,658.88%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.90
Upside: +274.10%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $0.82
Upside: +3,184.67%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.94
Upside: +1,601.03%